Inovio COVID-19 Vaccine Trial Delayed By FDA Partial Hold

The US FDA appears to have concerns about the device used to administer the vaccine.

Delayed
Inovio's COVID-19 vaccine Phase II/III trial is delayed • Source: Shutterstock

More from COVID-19

More from Scrip